Zobrazeno 1 - 4
of 4
pro vyhledávání: '"O. M. Senderova"'
Autor:
E. S. Eniseeva, K. V. Protasov, Y. A. Reut, O. M. Senderova, N. V. Shcherbakova, N. V. Petronchak
Publikováno v:
Acta Biomedica Scientifica, Vol 3, Iss 2, Pp 121-124 (2018)
Women of childbearing age without cardiovascular risk factors have low risk of acute myocardial infarction. Pregnancy has been shown to increase the risk of myocardial infarction compared to the risk in non-pregnant women of similar age. Acute myocar
Externí odkaz:
https://doaj.org/article/6875f308ffb34c45ab090cd3c2a4eb65
Autor:
E. G. lisina, N. T. Siordiya, P. A. Butylin, A. A. Silyutina, N. M. Matyukhina, O. M. Senderova, E. S. Fokina, V. A. Ovsepyan, E. G. Lomaia, A. Yu. Zaritskiy
Publikováno v:
Онкогематология, Vol 12, Iss 3, Pp 8-16 (2017)
Introduction. JAK2V617F mutation is detected in approximately 50 % of patients with essential thrombocytosis (ET) and primary myelofibrosis (PMF). In 2013 most of the JAK2 negative patients showed mutations in the CALR gene. Diagnostic value of JAK2
Externí odkaz:
https://doaj.org/article/4cbcde7263a74b05a482b52c9b4815e2
Autor:
E. Yu. Chelysheva, O. V. Lazareva, A. G. Turkina, O. Yu. Vinogradova, L. V. Gavrilova, M. V. Galayko, D. B. Dasheeva, A. S. Luchinin, S. V. Meresiy, O. M. Senderova, A. A. Shutylev, A. A. Kulikovskiy, S. M. Kulikov
Publikováno v:
Russian journal of hematology and transfusiology. 67:351-366
Introduction. Given the possibility of preserving molecular remission in 40–60 % of patients with chronic myeloid leukemia (CML) with a stable deep molecular response (MR) after discontinuation of tyrosine kinase inhibitors (TKI), it is important t
Autor:
S M, Kulikov, O Iu, Vinogradova, E Iu, Chelysheva, I A, Tishchenko, M A, Galaĭko, O V, Lazareva, O M, Senderova, V M, Pepeliaeva, S V, Meresiĭ, A S, Luchinin, V A, Ovsepian, G I, Miliutina, L V, Gavrilova, L B, Avdeeva, A L, Neverova, A G, Turkina
Publikováno v:
Terapevticheskii arkhiv. 86(7)
To assess the main epidemiological characteristics of chronic myeloid leukemia (CML) in the Russian Federation.A planned epidemiological prospective study was conducted in 2009-2012 in 6 Russian regions with the total number of 10.1 million inhabitan